Upcoming Webinar: Screening for MASH in Community Settings

Register today!

Event Description

Petauri Kinect and MASHNET are thrilled to invite you to their latest webinar, “Screening for MASH in Community Settings.” This session brings together frontline leaders to explore best practices in Metabolic Dysfunction–Associated Steatohepatitis (MASH) care delivery including effective screening methods and their impact on community health. 

This work is supported by Novo Nordisk.

Event Details

Date: Tuesday, June 3, 2025

Time: 5-6 PM EST

Location: Online (Zoom)

Please register by Friday, May 30, 2025.

This session is especially relevant for:

• medical professionals interested in optimizing MASH care delivery
• leaders with a focus on population health
• allied health professionals in primary care, bariatric medicine, endocrinology, cardiology and nephrology
• care coordinators and community advocates
• quality improvement specialists
• implementation science researchers

You can submit your questions in advance through the Zoom registration form. We also welcome you to share this invitation with interested colleagues.

Featured Speakers

This event will feature an insightful dialogue between two expert clinicians and researchers in the field of hepatology.

Dr. Arpan Mohanty, MD, MSc
Director of Clinical Research | Staff Hepatologist
Boston Medical Center

Dr. Arpan Mohanty is the Director of Clinical Research and a Staff Hepatologist at Boston Medical Center. She also serves as an Assistant Professor of Medicine in the Gastroenterology department at Boston University Chobanian & Avedisian School of Medicine. Dr. Mohanty is renowned for her contributions to hepatology and clinical research, with a focus on advancing patient care and medical education.

Dr. Panagiotis Trilianos, MD
Internist and Hepatologist
The Liver Clinic at NeighborHealth

Dr. Panagiotis Trilianos is an internist and hepatologist at The Liver Clinic at NeighborHealth. With extensive experience in liver disease management, Dr. Trilianos is dedicated to providing comprehensive care to his patients. His expertise in hepatology and commitment to improving health outcomes make him a valuable asset to the medical community. Together, these two clinical leaders will explore MASH screening best practices, the role of community-based interventions and the meaning of these approaches for population health outcomes.